Shareholder alert: ademi llp investigates whether revance therapeutics, inc. has obtained a fair price for its public shareholders

Milwaukee , aug. 15, 2024 /prnewswire/ -- ademi llp is investigating revance (nasdaq: rvnc) for possible breaches of fiduciary duty and other violations of law in its transaction with crown. click here to learn how to join our investigation https://www.ademilaw.com/case/revance-therapeutics-inc-0 or call guri ademi toll-free at 866-264-3995.
RVNC Ratings Summary
RVNC Quant Ranking